Houston-area company may be developing next hot weight-loss drug
Lexicon Pharmaceuticals, headquartered in The Woodlands, announced it will exclusively license its drug LX9851 to the maker ...
Hosted on MSN9mon
Weight loss drug contender Zealand Pharma jumps 18% on trial results
Zealand Pharma shares popped on Friday on positive weight loss results from long-acting amylin analog petrelintide. The company said petrelintide may produce similar weight loss results and a ...
Wall Street Journal19d
Roche Agrees to Develop Weight-Loss Therapy With Zealand Pharma
Roche Holding agreed a collaboration and licensing deal with Zealand Pharma to co-develop a weight-loss treatment using its ...
Wall Street Journal19d
Roche, Zealand Pharma Strike $5.3 Billion Weight-Loss Therapy Deal
Roche Holding said it would pay Danish biotechnology research company Zealand Pharma up to $5.3 billion under an agreement to co-develop a weight-loss treatment as the companies double down on ...
Medscape19d
Implementation of a Weight Management Pharmaceutical Care Service
Conclusions: The Auburn University Pharmaceutical Care ... of point-of-care devices that are used for weight loss and fitness, such as scales, body composition analyzers, pedometers, and heart ...
Zealand Pharma upgraded to Overweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst Laura Hindley upgraded Zealand Pharma (ZLDPF) to Overweight from Equal Weight with a DKK 750 price target The ...
Morningstar19d
Roche Agrees to Develop Weight-Loss Therapy With Zealand Pharma
Roche Holding agreed a collaboration and licensing deal with Zealand Pharma to co-develop a weight-loss treatment using its CT-388 medicine combined with Zealand Pharma's petrelintide. The Swiss ...